Director, Cardiac Cath Lab, PERT, & Structural Heart
Manatee Memorial Hospital
Dr. Mathews is an interventional cardiologist and endovascular specialist at Bradenton Cardiology Center in Bradenton, FL specializing in complex coronary interventions, structural heart procedures, endovascular therapies, and novel device research. He did graduate and professional training at Tufts University in Boston, MA where he received his MD and Master's in Health Communication at the Sackler School of Biomedical Sciences focusing on telemedicine and interactive education. He completed residency training and fellowship training in Cardiovascular Disease, Advanced Cardiac Imaging, and Interventional Cardiology at the Washington University School of Medicine in St. Louis, MO. He is currently national primary investigator in several trials and is actively involved in endovascular research.
Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Akura: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Bolt Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiva: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); CONTEGO MEDICAL: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis, Endovascular Division: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Evident Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Innova Vascular Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Intellvasc: Consultant (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Protexa: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); W. L. Gore: Grant/Research Support (Ongoing)
REVOLUTIONIZING MANAGEMENT STRATEGIES FOR ACS THROMBUS AND TREATMENT OF PULMONARY EMBOLISM
Sunday, March 9, 2025
12:30 PM – 1:30 PM ET
Welcome & Faculty Introduction
Sunday, March 9, 2025
12:45 PM – 12:48 PM ET
Lightning Flash Technology Overview & Case Presentations
Sunday, March 9, 2025
1:12 PM – 1:25 PM ET
Sunday, March 9, 2025
1:25 PM – 1:30 PM ET
Management of Acute Limb Ischemia
Monday, March 10, 2025
10:30 AM – 10:38 AM ET
Panel Discussion | Optimal Devices for the Treatment of CLI
Monday, March 10, 2025
11:58 AM – 12:15 PM ET
Have COMPASS and VOGERY Trials Really Changed Our Practice?
Monday, March 10, 2025
2:53 PM – 3:03 PM ET
Advancements in Management of VTE
Monday, March 10, 2025
3:59 PM – 4:07 PM ET
Live Case from MedStar Washington Hospital Center | Washington, DC
Monday, March 10, 2025
4:07 PM – 4:52 PM ET